SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose‐lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review-Reference-Cited by-同舟云学术

SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose‐lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review

Published:2021-01-04 Issue:3 Volume:38 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Escobar Carlos¹,Barrios Vivencio²,Cosín Juan³,Gámez Martínez José María⁴,Huelmos Rodrigo Ana Isabel⁵,Ortíz Cortés Carolina⁶,Torres Llergo Javier⁷,Requeijo Carolina⁸,Solà Ivan⁸,Martínez Zapata Mª José⁸

Affiliation:

1. Cardiology Department University Hospital La Paz Madrid Spain

2. Cardiology Department University Hospital Ramon y Cajal Madrid Spain

3. Cardiology Department Hospital Arnau de Vilanova Valencia Spain

4. Cardiology Department Hospital Son Llàtzer, Palma de Mallorca Baleares Spain

5. Cardiology Department University Hospital Fundación Alcorcón Madrid Spain

6. Cardiology Department Hospital San Pedro de Alcántara Caceres Spain

7. Cardiology Department Complejo Hospitalario de Jaen Spain

8. Centro Cochrane Iberoamericano Institut d'Investigació Biomèdica Sant Pau CIBERESP Barcelona Spain

Publisher

Wiley

Subject